-
Post-vaccination testing: After completing the 3-dose HBV vaccine series, 5–19% of people fail to seroconvert. Checking anti-HBs confirms adequate immune response.
-
Protective role: The temporal appearance of anti-HBs with resolution of HBV infection, and protection against reinfection, confirms anti-HBs as the key neutralising antibody. — Harrison's Principles of Internal Medicine 22E
-
Waning immunity: Vaccine-induced anti-HBs wanes over time, but immunological memory persists in competent responders, providing continued protection even when titers fall below 10 mIU/mL.
-
Coexistence with HBsAg: In ~5–10% of chronic HBV patients, low-level, low-affinity anti-HBs can co-exist with HBsAg — this does not indicate clearance, and may be associated with higher risk of fibrosis/cirrhosis. — Harrison's 22E